Adaptimmune Therapeutics PLC Sponsored ADRAdaptimmune Therapeutics PLC Sponsored ADRAdaptimmune Therapeutics PLC Sponsored ADR

Adaptimmune Therapeutics PLC Sponsored ADR

Tiada dagangan
Lihat pada Carta Super

Pemfailan SEC dan dokumen lain Adaptimmune Therapeutics PLC Sponsored ADR


Terokai dokumen syarikat terkini dan pemfailan SEC dari Adaptimmune Therapeutics PLC Sponsored ADR, termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.
Rakan kongsi data
Huraian
Reported date
Borang
2025
Q2 2025
Ogos 13, 2025
Quarterly report10-Q
Earnings release8-K
Q1 2025
Mei 13, 2025
Transcript
Quarterly report10-Q
Earnings release8-K
2024
Q4 2024
Mac 20, 2025
Transcript
Annual report10-K
Earnings release8-K
Q3 2024
Nov 13, 2024
Quarterly report10-Q
Earnings release8-K
Q2 2024
Ogos 12, 2024
Quarterly report10-Q
Earnings release8-K
FDA Announcement
Ogos 02, 2024
Slides
Press release
Collaboration
Mei 31, 2024
Press release
Q1 2024
Mei 15, 2024
Quarterly report10-Q
Earnings release8-K
2023
Q4 2023
Mac 06, 2024
Annual report10-K
Earnings release8-K
Q3 2023
Nov 08, 2023
Quarterly report10-Q
Earnings release8-K
Q2 2023
Ogos 09, 2023
Quarterly report10-Q
Earnings release8-K
Q1 2023
Mei 12, 2023
Quarterly report10-Q
Earnings release8-K
2022
Q4 2022
Mac 06, 2023
Annual report10-K
Earnings release8-K
Q3 2022
Nov 08, 2022
Quarterly report10-Q
Earnings release8-K
Q2 2022
Ogos 04, 2022
Quarterly report10-Q
Earnings release8-K
Q1 2022
Mei 09, 2022
Quarterly report10-Q
Earnings release8-K
2021
Q4 2021
Mac 14, 2022
Annual report10-K
Earnings release8-K
Q3 2021
Nov 04, 2021
Quarterly report10-Q
Earnings release8-K
Q2 2021
Ogos 09, 2021
Quarterly report10-Q
Earnings release8-K
Q1 2021
Mei 06, 2021
Quarterly report10-Q
Earnings release8-K
2020
Q4 2020
Feb 25, 2021
Annual report10-K
2019
Q4 2019
Feb 27, 2020
Annual report10-K
2018
Q4 2018
Feb 27, 2019
Annual report10-K
2017
Q4 2017
Mac 15, 2018
Annual report10-K
2016
Q4 2016
Mac 13, 2017
Annual report10-K